www.evommune.com/HealthcareFounded: 2020
Evommune, founded in 2020, is a biotechnology company that focuses on developing treatments for highly prevalent inflammatory diseases. Taking a tissue-based approach to insights and accelerating the development of transformative medicines for inflammatory diseases, Evommune seeks to create strategies to treat inflammatory disorders by developing treatments that address symptoms while also halting disease progression. Evommune is headquartered in Palo Alto, California.
